1. Target identification of small molecules based on chemical biology approaches
    Yushi Futamura et al, 2013, Molecular BioSystems CrossRef
  2. Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch
    Prabhat Singh Malik et al, 2014, Frontiers in Oncology CrossRef
  3. Statin and Bisphosphonate Induce Starvation in Fast-Growing Cancer Cell Lines
    Heidrun Karlic et al, 2017, International Journal of Molecular Sciences CrossRef
  4. Differential preventive activity of sulindac and atorvastatin in Apc+/Min-FCCCmice with or without colorectal adenomas
    Wen-Chi L Chang et al, 2018, Gut CrossRef
  5. RNA-Sequencing Analysis of HepG2 Cells Treated with Atorvastatin
    Camilla Stormo et al, 2014, PLoS ONE CrossRef
  6. The anti-lipidemic drug simvastatin modifies epigenetic biomarkers in the amphipod Gammarus locusta
    Nélson Alves et al, 2021, Ecotoxicology and Environmental Safety CrossRef
  7. Identification and analysis of the molecular targets of statins in colorectal cancer
    Ali Ahmadizad Firouzjaei et al, 2024, Pathology - Research and Practice CrossRef
  8. Altered microRNome Profiling in Statin-Induced HepG2 Cells: A Pilot Study Identifying Potential new Biomarkers Involved in Lipid-Lowering Treatment
    Tomás Zambrano et al, 2015, Cardiovascular Drugs and Therapy CrossRef
  9. Selected pharmacotherapy agents as antiproliferative and anti‐inflammatory compounds
    Mthanna AlKhalil et al, 2020, Drug Development Research CrossRef
  10. Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB)
    Qing Ma et al, 2019, BioMed Research International CrossRef
  11. Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery
    Hye Jin Jung et al, 2015, Archives of Pharmacal Research CrossRef
  12. CDK2 and CDK4 play important roles in promoting the proliferation of SKOV3 ovarian carcinoma cells induced by tumor-associated macrophages
    YANG YANG et al, 2014, Oncology Reports CrossRef
  13. Simvastatin enhances NMDA receptor GluN2B expression and phosphorylation of GluN2B and GluN2A through increased histone acetylation and Src signaling in hippocampal CA1 neurons
    Tingting Chen et al, 2016, Neuropharmacology CrossRef
  14. In Silico and Biophysical Techniques in Anticancer Drug Discovery Research
    Aljabal Ghazi et al, 2024, null CrossRef
  15. Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells
    D. Kata et al, 2016, Neuroscience CrossRef